Global Population Sequencing Market to Reach $64,047.6 Million by 2030
Market Report Coverage - Global Population Sequencing Market
• Product Type – Kits and Assays, Platforms, Software Tools • Application- Human Health, Molecular Forensics, Blockchain in Genomics • Methods- Whole Genome Sequencing, Whole Exome Sequencing, Single-Read Sequencing, and Other Sequencing Methods • Technology- Next-Generation Sequencing, Polymerase Chain Reaction and Other Technologies
• Rising Adoption of Large-Scale Sequencing to Understand the Genomics of Susceptibility and Resistance from COVID-19 • Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders • Global Surge in Direct-to-Consumer (DTC) Genetic Testing
• Lack of Infrastructure to Maintain, Store and Share Sensitive Genomic Data • Absence of Sufficient Funding for Development of High-Throughput Genomic Software Tools • Poor Reducibility and Translatability of Data in Clinical Practice
• Advancing Precision Medicine with Blockchain-Powered Artificial Intelligence • Technological Advancements in Sample Preparation for Population Sequencing • Increased Population Engagement and Data Management
Key Companies Profiled
Thermo Fisher Scientific, Illumina Inc., Pacific Biosciences of California, Inc., Qiagen N.V., Oxford Nanopore Technologies, Inc., and Agilent Technologies, Inc., Genuity Science, F. Hoffman La-Roche Ltd., Nebula Genomics, Inc., Helix Opco, LLC, Beijing Genomics Institute, and Agilent Technologies, Inc.
Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the global population sequencing market? • What is the potential impact of sequencing and biotechnological advancement in the application of genomic medicine and translational research? • What is the current market expense along with future expected expenses in population sequencing initiatives? • How population sequencing helped genomic tests to become a prominent tool for diagnostics in various clinical applications? • What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?
• How is each segment of the market expected to grow during the forecast period from 2020 to 2030 based on: o product type o method o application o technology o country • Who are the leading players with significant offerings to the global population sequencing market? What is the expected market dominance for each of these leading players? • Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the population sequencing industry?
As per the analysis, the population sequencing market is projected to reach $64,047.6 million by 2030 from $21,730.4 million in 2020, at a CAGR of 11.41% during the forecast period, 2020-2030. Growth in this market is expected to be driven by the rising adoption of large-scale sequencing to understand the genomics of susceptibility and resistance from COVID-19, increasing adoption of personalized medicine for the screening and diagnosis of genetic disorders, and a global surge in direct-to-consumer genetic testing. However, there are significant challenges that are restraining the market growth, such as lack of infrastructure to maintain, store, and share sensitive genomic data, absence of sufficient funding for the development of high-throughput genomic software tools, and poor reducibility and transability of data in clinical practice.
The market is favored by the technological advancements in the sequencing, and computational analysis solutions for large volume of genetic data enabling deep understanding of the genetic variants for the development of diagnostics, drug discovery, and translational research.
Furthermore, several sequencing companies are focusing on the development of high-throughput sequence platforms and polymerase chain reaction platforms, with higher sensitivity and low turn-around time to benefit the patients, enabling patient-based outcomes and implementing genomic medicine.
Within the research report, the market is segmented on the basis of product type, application, methods, and technology. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of rapid diagnostics providing information on genetic mutation and optimal candidates for adjuvant chemotherapy or hormonal therapy. Due to the diverse product portfolio and intense market penetration, Illumina, Inc. has been a pioneer in this field and has been a significant competitor in this market.
The population sequencing market provided immense growth opportunities for the companies providing technology and infrastructure for large-scale health initiatives, such as Color Genomics, Inc., Helix Opco, LLC, and big data companies such as Genuity Science
Countries Covered • U.S. • Canada • U.K. • Germany • Denmark • Ireland • Estonia • Finland • Netherlands • China • Japan • Saudi Arabia • Turkey • Qatar
Our reports have been used by over 10K customers, including:
Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and growing investment in R&D. The technological advancements...
Immunohematology Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunohematology Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunohematology Tests pipeline products with comparative analysis of the products...
224 pages •
By The Business Research Company
• Dec 2020
Next Generation Sequencing Global Market Opportunities And Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market. Description: Where is the largest and fastest growing...
The Global Proteomics Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Proteomics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Proteomics partnering deals Disclosed headlines, upfronts, milestones and royalties by...
Hepatitis Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Hepatitis Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Tests pipeline products with comparative analysis of the products at various stages...
The oligonucleotide synthesis market is expected to register a CAGR of 12.3% during the forecast period. The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and...
The global metabolomics market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period. The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing...
The global RNA interference (RNAi) drug delivery market grew at a CAGR of around 7% during 2014-2019. Ribonucleic acid interference (RNAi) drug delivery refers to a therapeutic solution to monitor gene expression or mutations. RNAi drug delivery is usually administered through intravenous, intra-dermal and intraperitoneal...
Genome Engineering Market Research Report by Technology (Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nuclease, and Zinc Finger Nuclease), by Application (Animal Genetic Engineering, Cell Line Engineering, and Plant Genome Engineering), by End-User - Global Forecast to 2025 - Cumulative...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.